Account
Publications
12.10.2022
ISPOR 2022: Comparing And Contrasting Early Access...

Identifying EAPs and understanding the opportunities that would best complement manufacturer pricing...

Read more
04.05.2022
PMA Insights: Week 18

A short, 60 seconds read that summarises 4 handpicked articles that are worth reading about: Regulat...

Read more
Articles
28.04.2022
Regulators are giving early access to medicines, b...

Introduction Early Access Programs (EAPs) help to give people with life threatening or seriously deb...

Read more
Articles
19.04.2022
Could Brexit lead to earlier access to medicines f...

Introduction Following Brexit, regulatory oversight in the UK has switched from the European Medicin...

Read more
Articles
13.04.2022
How do you win the race to market? Our top conside...

Introduction Early Access Programs, also known as special access programs, give patients access to m...

Read more
Articles
09.09.2020
Early access to medicines in the UK

This newsletter will discuss the early access processes operating within the UK and discuss the adva...

Read more
Articles
27.02.2020
Legislative updates in France and Italy

The final details of the decree may differ from those detailed above, making the precise nature of t...

Read more
Articles
04.09.2019
Are access agreements essential for NICE access

This study aimed to compare the use of financial agreements for oncology and non-oncology appraisals...

Read more
Publications
14.11.2018
ISPOR 2018 Exploring biosimilar market access

Biosimilars are becoming more widely available across Europe, with many payers at each level involve...

Read more

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.